Filing Details
- Accession Number:
- 0001267602-18-000015
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-01-18 16:53:56
- Reporting Period:
- 2018-01-16
- Accepted Time:
- 2018-01-18 16:53:56
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1267602 | Alimera Sciences Inc | ALIM | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1564990 | Philip Ashman | 6120 Windward Parkway Suite 290 Alpharetta GA 30005 | Svp, Eu Managing Director | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2018-01-16 | 12,750 | $1.24 | 38,250 | No | 4 | S | Direct | |
Common Stock | Disposition | 2018-01-17 | 12,750 | $1.23 | 25,500 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- This sale was effected pursuant to the Reporting Person's Rule 10b5-1 Trading Plan dated March 10, 2017.